Revolution Medicines, Inc. (RVMD)

Revolution Medicines Statistics

Total Valuation

RVMD has a market cap or net worth of $8.21 billion. The enterprise value is $6.21 billion.

Market Cap	8.21B
Enterprise Value	6.21B

Important Dates

The next estimated earnings date is Wednesday, November 5, 2025, after market close.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

RVMD has 186.93 million shares outstanding. The number of shares has increased by 23.61% in one year.

Current Share Class	186.93M
Shares Outstanding	186.93M
Shares Change (YoY)	+23.61%
Shares Change (QoQ)	+0.23%
Owned by Insiders (%)	2.45%
Owned by Institutions (%)	90.33%
Float	158.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.40
P/TBV Ratio	4.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.79, with a Debt / Equity ratio of 0.07.

Current Ratio	11.79
Quick Ratio	11.58
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -46.61% and return on invested capital (ROIC) is -30.28%.

Return on Equity (ROE)	-46.61%
Return on Assets (ROA)	-26.47%
Return on Invested Capital (ROIC)	-30.28%
Return on Capital Employed (ROCE)	-39.98%
Revenue Per Employee	n/a
Profits Per Employee	-$1.52M
Employee Count	534
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-753,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.10% in the last 52 weeks. The beta is 1.12, so RVMD's price volatility has been higher than the market average.

Beta (5Y)	1.12
52-Week Price Change	-2.10%
50-Day Moving Average	39.19
200-Day Moving Average	39.73
Relative Strength Index (RSI)	58.04
Average Volume (20 Days)	2,186,966

Short Selling Information

The latest short interest is 18.05 million, so 9.66% of the outstanding shares have been sold short.

Short Interest	18.05M
Short Previous Month	16.53M
Short % of Shares Out	9.66%
Short % of Float	11.39%
Short Ratio (days to cover)	8.86

Income Statement

Revenue	n/a
Gross Profit	-604.71M
Operating Income	-897.50M
Pretax Income	-812.81M
Net Income	-812.06M
EBITDA	-890.70M
EBIT	-897.50M
Earnings Per Share (EPS)	-$4.53

Balance Sheet

The company has $2.14 billion in cash and $132.79 million in debt, giving a net cash position of $2.00 billion or $10.72 per share.

Cash & Cash Equivalents	2.14B
Total Debt	132.79M
Net Cash	2.00B
Net Cash Per Share	$10.72
Equity (Book Value)	1.87B
Book Value Per Share	9.98
Working Capital	1.99B

Cash Flow

In the last 12 months, operating cash flow was -$684.90 million and capital expenditures -$15.46 million, giving a free cash flow of -$700.36 million.

Operating Cash Flow	-684.90M
Capital Expenditures	-15.46M
Free Cash Flow	-700.36M
FCF Per Share	-$3.75

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RVMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.61%
Shareholder Yield	-23.61%
Earnings Yield	-9.89%
FCF Yield	-8.53%

Analyst Forecast

The average price target for RVMD is $73.56, which is 67.49% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$73.56
Price Target Difference	67.49%
Analyst Consensus	Strong Buy
Analyst Count	16
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1